BioAdvance News

Amyvid™ (Florbetapir F 18 Injection) Recommended for Approval in Europe as a Diagnostic Tool for PET Imaging of Beta-Amyloid Plaque Density

By WebmasterOctober 18, 2012November 1st, 2024No Comments

Amyvid™ (Florbetapir F 18 Injection) Recommended for Approval in Europe as a Diagnostic Tool for PET Imaging of Beta-Amyloid Plaque Density
Read more here

Previous PostAvid's Amyvid Recommended for Approval In Europe as Diagnostic Tool for Alzheimer's Disease
Next PostBioAdvance Expands Team to Support Portfolio Companies and New Investments

Amyvid™ (Florbetapir F 18 Injection) Recommended for Approval in Europe as a Diagnostic Tool for PET Imaging of Beta-Amyloid Plaque Density

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostAvid's Amyvid Recommended for Approval In Europe as Diagnostic Tool for Alzheimer's Disease

Next PostBioAdvance Expands Team to Support Portfolio Companies and New Investments